Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeong H Joo

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Molecular Therapy. Nucleic Acids|November 10, 2025
Precision gene editing: The power of CRISPR-Cas in modern geneticsJeong H Joo, Soogene Lee, Keun P Kim
Journal of Microbiology (Seoul, Korea)|July 6, 2026
Prophase roles of replication protein A in crossover formation and meiotic progressionRose M Lee, Keun Pil Kim, Jeong H Joo
Journal of Microbiology (Seoul, Korea)|December 11, 2023
A Method for Physical Analysis of Recombination Intermediates in Saccharomyces cerevisiaeKiwon Rhee, Hyungseok Choi, Keun P Kim, et al.
Nucleic Acids Research|October 17, 2019
Recruitment of Rec8, Pds5 and Rad61/Wapl to meiotic homolog pairing, recombination, axis formation and S-phaseSoogil Hong, Jeong H Joo, Hyeseon Yun, et al.
Nucleic Acids Research|July 27, 2025
Recombination-coupled DNA synthesis facilitates post-invasion steps in meiotic crossover and noncrossover formationsHyungseok Choi, Jun Seo Lee, Jeong H Joo, et al.
Nucleic Acids Research|February 10, 2024
RPA interacts with Rad52 to promote meiotic crossover and noncrossover recombinationJeong H Joo, Soogil Hong, Mika T Higashide, et al.
Biopharmaceutics & Drug Disposition|June 5, 2003
Pharmacokinetic scaling of SJ-8029, a novel anticancer agent possessing microtubule and topoisomerase inhibiting activities, by species-invariant time methodsBeom S Shin, Dong H Kim, Chang Y Cho, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 9, 2025
Biallelic BRF2 mutations disrupt redox homeostasis as etiological factors in syndromic immunodeficiency and developmental disordersSeobin Yoon, Seungbok Lee, Haeyoon Kwon, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Molecular Therapy. Nucleic Acids|November 10, 2025
Precision gene editing: The power of CRISPR-Cas in modern geneticsJeong H Joo, Soogene Lee, Keun P Kim
Journal of Microbiology (Seoul, Korea)|July 6, 2026
Prophase roles of replication protein A in crossover formation and meiotic progressionRose M Lee, Keun Pil Kim, Jeong H Joo
Journal of Microbiology (Seoul, Korea)|December 11, 2023
A Method for Physical Analysis of Recombination Intermediates in Saccharomyces cerevisiaeKiwon Rhee, Hyungseok Choi, Keun P Kim, et al.
Nucleic Acids Research|October 17, 2019
Recruitment of Rec8, Pds5 and Rad61/Wapl to meiotic homolog pairing, recombination, axis formation and S-phaseSoogil Hong, Jeong H Joo, Hyeseon Yun, et al.
Nucleic Acids Research|July 27, 2025
Recombination-coupled DNA synthesis facilitates post-invasion steps in meiotic crossover and noncrossover formationsHyungseok Choi, Jun Seo Lee, Jeong H Joo, et al.
Nucleic Acids Research|February 10, 2024
RPA interacts with Rad52 to promote meiotic crossover and noncrossover recombinationJeong H Joo, Soogil Hong, Mika T Higashide, et al.
Biopharmaceutics & Drug Disposition|June 5, 2003
Pharmacokinetic scaling of SJ-8029, a novel anticancer agent possessing microtubule and topoisomerase inhibiting activities, by species-invariant time methodsBeom S Shin, Dong H Kim, Chang Y Cho, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 9, 2025
Biallelic BRF2 mutations disrupt redox homeostasis as etiological factors in syndromic immunodeficiency and developmental disordersSeobin Yoon, Seungbok Lee, Haeyoon Kwon, et al.
Pageof 1